Latest Period
n/a
Security Snapshot
Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO) Institutional Ownership
CUSIP: 03835L405
13F Institutional Holders and Ownership History from Q4 2024 to Q3 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.30
- Type / Class
- Equity / Common stock, par value $0.001 per share
- Symbol
- APVO on Nasdaq
- Shares outstanding
- 3,581,500
- Price per share
- $0.30
- Price from insider filings
- $0.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- APVO - Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share is tracked under CUSIP 03835L405.
- Latest finished 13F holder period is not available.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 1 to 0 between Q2 2025 and Q3 2025.
- Reported value moved from $30,500 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Schedule 13D/13G
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 03835L405?
CUSIP 03835L405 identifies APVO - Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03835L405:
Significant Owners of Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 10% | $107,445 | 358,150 | Ayrton Capital LLC | 30 Jun 2025 | |||
| CVI Investments, Inc. | 6.2% | $138,000 | 200,000 | CVI Investments, Inc. | 03 Apr 2025 | |||
| Hudson Bay Capital Management LP | 5% | 0% | $52,853 | 76,598 | 0% | Hudson Bay Capital Management LP | 31 Dec 2024 |